Abstract:Background: Significant progress has been made over the past decade in measuring the chemical components of the exposome, providing transformative population-scale frameworks in probing the etiologic link between environmental factors and disease phenotypes. While the analytical technologies continue to evolve with reams of data being generated, there is an opportunity to complement exposome-wide association studies (ExWAS) with functional analyses to advance etiologic search at organismal, cellular, and molecular levels. Objectives: Exposomics is a transdisciplinary field aimed at enabling discovery-based analysis of the nongenetic factors that contribute to disease, including numerous environmental chemical stressors. While advances in exposure assessment are enhancing population-based discovery of exposome-wide effects and chemical exposure agents, functional screening and elucidation of biological effects of exposures represent the next logical step toward precision environmental health and medicine. In this work, we focus on the use, strategies, and prospects of alternative approaches and model systems to enhance the current human exposomics framework in biomarker search and causal understanding, spanning from bench-based nonmammalian organisms and cell culture to computational new approach methods (NAMs). Discussion: We visit the definition of the functional exposome and exposomics and discuss a need to leverage alternative models as opposed to mammalian animals for delineating exposome-wide health effects. Under the "three Rs" principle of reduction, replacement, and refinement, model systems such as roundworms, fruit flies, zebrafish, and induced pluripotent stem cells (iPSCs) are advantageous over mammals (e.g., rodents or higher vertebrates). These models are cost-effective, and cell-specific genetic manipulations in these models are easier and faster, compared to mammalian models. Meanwhile, in silico NAMs enhance hazard identification and risk assessment in humans by bridging the translational gaps between toxicology data and etiologic inference, as represented by in vitro to in vivo extrapolation (IVIVE) and integrated approaches to testing and assessment (IATA) under the adverse outcome pathway (AOP) framework. Together, these alternatives offer a strong toolbox to support functional exposomics to study toxicity and causal mediators underpinning exposure-disease links. https://doi.org/10.1289/EHP13120.

Role of model organisms and nanocompounds in human health risk assessment

New approach methodologies in human regulatory toxicology - Not if, but how and when!

Human biomonitoring and toxicokinetics as key building blocks for next generation risk assessment

An ecotoxicological view on neurotoxicity assessment

In Silico Nanosafety Assessment Tools And Their Ecosystem-Level Integration Prospect

Computational Nanotoxicology Models for Environmental Risk Assessment of Engineered Nanomaterials

High-throughput screening paradigms in ecotoxicity testing: Emerging prospects and ongoing challenges

Nanomaterials in the aquatic environment: A European Union–United States perspective on the status of ecotoxicity testing, research priorities, and challenges ahead

Uncertainties in Human Health Risk Assessment of Environmental Contaminants: A Review and Perspective.

Seminar: Functional Exposomics and Mechanisms of Toxicity-Insights from Model Systems and NAMs

A critical review on the toxicological and epidemiological evidence integration for assessing human health risks to environmental chemical exposures

Immunotoxicity of nanomaterials in health and disease: Current challenges and emerging approaches for identifying immune modifiers in susceptible populations

Setting the stage for next-generation risk assessment with non-animal approaches: the EU-ToxRisk project experience

Bridging the gap: Innovative human-based in vitro approaches for nanomaterials hazard assessment and their role in safe and sustainable by design, risk assessment, and life cycle assessment

Recent Advances in Environmental Toxicology: Exploring Gene Editing, Organ-on-a-Chip, Chimeric Animals, and In Silico Models

Protecting Human and Animal Health: The Road from Animal Models to New Approach Methods

Transforming Toxicity Assessment through Microphysiology, Bioprinting, and Computational Modeling

Modeling Approaches for Characterizing and Evaluating Environmental Exposure to Engineered Nanomaterials in Support of Risk-Based Decision Making

Applying quantitative structure–activity relationship approaches to nanotoxicology: Current status and future potential

Alternative approaches to vertebrate ecotoxicity tests in the 21st century: A review of developments over the last 2 decades and current status

In silico approaches in organ toxicity hazard assessment: Current status and future needs for predicting heart, kidney and lung toxicities